Upstream Bio IPO

upstreambio.com

Upsteam Bio develops therapies for asthma, inflammatory and allergic diseases.

Founded2021
Total Funding to Date$200MM
Register for Details

For more details on financing and valuation for Upstream Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Upstream Bio Ticker Symbol

Upstream Bio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Upstream Bio Stock Price

The stock price for Upstream Bio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Upstream Bio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
6/2/2022 Series A $200MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Upstream Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector